Pharmaceutical Education and Practice

Pharma Education 2027 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the 18^th International Conference on Pharmaceutical Education & Practice, scheduled to be held during February 15-16, 2027 in Rome, Italy. This Pharmaceutical Sciences Conference includes a wide range of Keynote presentations, Plenary talks, Symposia, Workshops, Exhibitions, Poster presentations and Career development programs.

The conference will be organized around the theme The Future of Pharmacy: Integrating AI, Personalized Medicine & Advanced Therapeutics. Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Pharma, Pharmaceutical science, Biopharmaceutics and Radiopharmaceuticals and share the cross-cultural experiences of various treatment procedures.

Pharma Education 2027 is organized by Conference Series LLC Ltd. Conference Series LLC Ltd organizes 3000+ Global Events every year across USA, Canada, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The Conference Series LLC Ltd website will provide you list and details about the conferences organized worldwide.

Why to Attend???

Pharma Education 2027 is a multidisciplinary program with broad participation from around the globe focused on learning about pharmaceutical sciences, innovations & latest advancements. This conference provides a unique opportunity to reach the largest assemblage of participants from the pharmaceutical sciences community, including academia, pharmaceutical research entities, medical groups, pharmaceutical, biomedical and medical device industries along with related associations & societies. It also provides an opportunity to establish a scientific network between peers belonging to both industry and academia. We cordially invite all concerned people to join us at our event and make it successful by your participation.

Pharma Education 2027 conference is a blend of multiple disciplines where it provides the platform to discuss topics like Drug Discovery, Pharmaceutical Manufacturing, Novel Drug Delivery Systems, Nanotechnology, Radiopharmaceuticals, Clinical Trials, GMP, GCP & Regulatory Affairs, Packaging and Marketing. It will educate healthcare researchers about discovery, development and manufacturing of new drugs. This conference conducts presentations, distributes information, provides opportunities to meet with current and potential scientists, highlights new pharmaceutical research & developments, and provides name recognition at this 2-days event. World renowned speakers and the most recent techniques, developments, and the newest updates in Pharmaceutical Research are hallmarks of this conference.

Who Should Attend and Who You’ll Meet

Industry:

Directors/Senior Directors/Executive Directors, CEO’s, Presidents/Vice Presidents, Heads/Leaders, Partners, Research Associates, Research Scientist of pharmaceutical, biomedical, biopharmaceutical and medical devices industries.

Leaders in:

Academia:

Deans, Professors/Assistant Professors/Associate Professors, Research Scholars, Scientists and Students related to Pharmaceutical and Medical Sciences.

Track-1: Pharmaceutical Education & Innovative Teaching

This track explores the transformation of pharmaceutical education through innovative teaching methodologies, digital learning, simulation, and competency-based education. Topics include active learning, problem-based learning, virtual classrooms, laboratory simulation, experiential education, and interprofessional training. Discussions will focus on preparing future pharmacists for evolving healthcare environments and integrating AI-driven educational tools into pharmacy curricula. Participants can share research on student assessment, faculty development, curriculum design, and educational technologies. The track also addresses professional skills, communication, clinical decision-making, lifelong learning, and strategies for improving educational quality across undergraduate, postgraduate, and continuing pharmacy education programs.

Track-2: Artificial Intelligence in Pharmacy

This track focuses on the rapidly expanding role of Artificial Intelligence (AI) across pharmaceutical sciences and pharmacy practice. Topics include machine learning, deep learning, natural language processing, predictive analytics, AI-assisted drug discovery, clinical decision support, and automated medication management. Researchers can discuss applications of AI in drug development, pharmacovigilance, diagnostics, personalized therapy, and pharmaceutical manufacturing. The track also examines ethical considerations, data quality, algorithmic bias, privacy, and regulatory challenges. Emphasis will be placed on how AI technologies can improve efficiency, accuracy, patient outcomes, research productivity, and the future delivery of pharmacy and healthcare services.

Track-3: Personalized & Precision Medicine

This track highlights advances in personalized medicine and precision healthcare, focusing on therapies tailored to individual patient characteristics. Topics include pharmacogenomics, genomic medicine, biomarker discovery, molecular profiling, precision dosing, and patient-specific therapeutic strategies. Discussions will explore how genetic, environmental, lifestyle, and clinical factors influence treatment responses. Researchers can present developments in pharmacogenetic testing, companion diagnostics, targeted therapies, and individualized medication management. The track also addresses implementation challenges, ethical considerations, accessibility, clinical integration, and healthcare economics. Participants will explore how precision approaches are transforming traditional pharmaceutical care and improving therapeutic efficacy and patient safety.

Track-4: Advanced Drug Delivery Systems

This track explores innovative approaches for improving drug delivery, bioavailability, targeting, and therapeutic performance. Topics include nanomedicine, liposomes, nanoparticles, micelles, implantable systems, transdermal delivery, inhalation systems, and controlled-release technologies. Researchers can discuss advanced formulations designed to overcome biological barriers and deliver medicines precisely to specific tissues or cells. The track also covers targeted drug delivery, smart delivery platforms, stimuli-responsive systems, and novel routes of administration. Emphasis will be placed on translating laboratory innovations into clinically effective products, addressing manufacturing challenges, stability, scalability, regulatory requirements, and patient-centered approaches for next-generation pharmaceutical therapies.

Track-5: Drug Discovery & Development

This track covers emerging strategies in drug discovery and pharmaceutical development, from identifying therapeutic targets to clinical evaluation. Topics include target identification, computational drug design, high-throughput screening, medicinal chemistry, molecular modeling, lead optimization, and preclinical testing. Participants can explore the use of AI and computational technologies to accelerate discovery pipelines and reduce development costs. Discussions will also address pharmacokinetics, pharmacodynamics, toxicity assessment, formulation development, and translational research. The track provides opportunities to examine innovative approaches for developing safer, more effective medicines and overcoming challenges associated with the complex and increasingly technology-driven pharmaceutical development process.

Track-6: Clinical Pharmacy & Patient-Centered Care

This track focuses on the evolving role of clinical pharmacists in optimizing medication therapy and improving patient outcomes. Topics include medication therapy management, clinical interventions, pharmaceutical care, medication reconciliation, adherence, and patient safety. Researchers can present evidence-based approaches for managing chronic diseases, complex therapies, polypharmacy, and high-risk medications. The track also explores collaborative practice involving pharmacists, physicians, nurses, and other healthcare professionals. Discussions will emphasize patient-centered care, clinical decision-making, therapeutic monitoring, and outcome evaluation. Participants will examine strategies that strengthen the contribution of pharmacy professionals to modern healthcare systems and multidisciplinary clinical practice.

Track-7: Pharmacology & Therapeutic Innovations

This track addresses developments in pharmacology, mechanisms of drug action, therapeutic targets, and emerging treatment strategies. Topics include molecular pharmacology, receptor biology, signaling pathways, pharmacodynamics, toxicology, and experimental therapeutics. Researchers can present discoveries involving novel therapeutic targets, innovative drug candidates, biologics, combination therapies, and next-generation medicines. The track will examine mechanisms underlying drug efficacy, resistance, adverse effects, and treatment response. Particular attention will be given to translational research connecting laboratory findings with clinical applications. Participants will explore how advances in pharmacological sciences contribute to safer, more effective, and precision-oriented therapeutic interventions.

Track-8: Biopharmaceuticals & Advanced Therapeutics

This track explores the rapidly developing field of biopharmaceuticals, including biologics, monoclonal antibodies, vaccines, recombinant proteins, cell therapies, and gene therapies. Discussions will focus on the development, formulation, manufacturing, characterization, and quality control of complex therapeutic products. Researchers can examine advanced therapeutics, biosimilars, personalized biologics, and emerging cell and gene-based approaches. Topics also include stability, delivery challenges, immunogenicity, regulatory considerations, and commercialization. The track provides a platform for discussing how innovative biological medicines are transforming modern healthcare and creating new opportunities for treating complex, rare, chronic, and previously difficult-to-treat diseases.

Track-9: Pharmacovigilance & Medication Safety

This track focuses on ensuring the safety and effectiveness of medicines throughout their lifecycle. Topics include adverse drug reaction monitoring, signal detection, risk assessment, medication errors, post-marketing surveillance, and benefit-risk evaluation. Participants can explore the use of AI, real-world data, and advanced analytics for identifying emerging safety signals and improving pharmacovigilance systems. Discussions will address patient reporting, regulatory requirements, safety databases, and international collaboration. The track emphasizes strategies for reducing medication-related harm and strengthening drug safety monitoring, while promoting evidence-based decision-making and safer pharmaceutical practices across clinical, community, and industrial healthcare environments.

Track-10: Pharmaceutical Technology & Manufacturing

This track explores innovations in pharmaceutical manufacturing, formulation technologies, process optimization, and quality assurance. Topics include continuous manufacturing, process analytical technology, automation, robotics, advanced formulation, scale-up, and manufacturing efficiency. Researchers can discuss Industry 4.0, digital manufacturing, artificial intelligence, smart factories, and data-driven production systems. The track also addresses quality-by-design, process validation, regulatory compliance, supply-chain resilience, and sustainability. Emphasis will be placed on developing reliable and flexible manufacturing systems capable of producing high-quality medicines efficiently. Participants will examine technologies shaping the future of pharmaceutical production and global medicine supply.

Track-11: Regulatory Affairs & Pharmaceutical Policy

This track examines the evolving landscape of pharmaceutical regulation, approval pathways, compliance, and healthcare policy. Topics include regulatory science, clinical trial regulations, drug approvals, quality standards, pharmacovigilance requirements, and international regulatory harmonization. Participants can discuss challenges associated with advanced therapies, personalized medicines, AI-based technologies, and novel pharmaceutical products. The track also considers intellectual property, market authorization, post-approval monitoring, and regulatory strategies for global product development. Researchers and industry professionals will explore how effective regulatory frameworks can encourage innovation while ensuring medicine quality, patient safety, ethical standards, and equitable access to new pharmaceutical technologies.

Track-12: Digital Pharmacy & Smart Healthcare

This track explores the integration of digital technologies into pharmacy practice, pharmaceutical services, and healthcare delivery. Topics include telepharmacy, mobile health applications, electronic prescribing, digital therapeutics, remote medication monitoring, wearable technologies, and clinical decision-support systems. Participants can examine how digital transformation is improving accessibility, medication management, patient engagement, and healthcare efficiency. Discussions will also address cybersecurity, interoperability, data privacy, digital literacy, and implementation challenges. The track highlights opportunities for pharmacists to contribute to technology-enabled healthcare and explores how smart pharmacy systems can support personalized, connected, efficient, and patient-centered pharmaceutical care.

Track-13: Nanotechnology & Nanomedicine

This track focuses on applications of nanotechnology in pharmaceutical research and advanced medicine. Topics include nanoparticles, nanocarriers, nanoformulations, targeted delivery, diagnostic nanotechnology, and theranostics. Researchers can present innovative approaches for improving drug solubility, stability, bioavailability, and site-specific delivery. The track will explore nanomedicine applications in cancer therapy, infectious diseases, neurological disorders, and other complex conditions. Discussions will also cover nanotoxicology, biological interactions, manufacturing, characterization, regulatory challenges, and clinical translation. Participants will examine how nanoscale technologies are enabling next-generation therapeutic and diagnostic platforms with improved precision and treatment outcomes.

Track-14: Pharmaceutical Research & Translational Medicine

This track emphasizes the connection between pharmaceutical research and real-world clinical applications. Topics include translational research, laboratory-to-clinic pathways, preclinical models, biomarker development, clinical research, and therapeutic validation. Participants can explore strategies for accelerating the movement of promising discoveries into effective patient treatments. Discussions will address research reproducibility, interdisciplinary collaboration, clinical trial design, data integration, and commercialization. The track encourages collaboration between academic researchers, pharmaceutical companies, clinicians, and technology developers. Special attention will be given to innovative research models that bridge scientific discoveries with clinical practice and improved healthcare outcomes.

Track-15: Future Trends in Pharmacy Practice

This forward-looking track examines the future of pharmacy and emerging developments that will redefine the profession. Topics include AI-enabled pharmacy, precision therapeutics, automation, digital health, advanced clinical services, pharmacogenomics, remote care, and evolving pharmacist roles. Participants will explore how pharmacists can adapt to technological transformation, changing healthcare systems, and increasingly complex patient needs. Discussions will address workforce development, professional competencies, interdisciplinary collaboration, entrepreneurship, and innovative models of pharmaceutical care. The track provides a platform for envisioning next-generation pharmacy practice, emphasizing innovation, patient-centered services, clinical excellence, technology integration, and the expanding global role of pharmacy professionals.